Skip to main content
logo
Medicamen Organics Limited (NSE:MEDIORG)
India flag India · Delayed Price · Currency is INR
24.30
0.00 (0.00%)
Aug 19, 2026, 3:26 PM IST

Medicamen Organics Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
226.3226.3381.88252.72221.47209.75
Revenue Growth
-42.61%-40.74%51.11%14.11%5.59%-16.26%
Gross Profit
40.3240.32134.0394.7363.553.16
Operating Income
-46.48-46.4858.3340.1811.715.18
Net Income
-40.19-40.1940.4726.249.691.01
Earnings Per Share
-3.41-3.413.663.471.620.17
EPS Growth
--5.48%114.79%855.92%-58.46%

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
13.0313.0341.35.535.284.37
Total Debt
142.93142.93123.53126.57117.95102.46
Net Cash (Debt)
-129.9-129.9-82.23-121.04-112.67-98.08
Net Cash Growth
------
Net Cash Per Share
-11.02-11.02-7.44-16.00-18.78-16.35

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-45.95-45.95-45.43-36.62-5.840.37
Capital Expenditures
-17.38-17.38-24.47-3.51-2.89-6.16
Free Cash Flow
-63.34-63.34-69.9-40.13-8.73-5.79
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
17.82%17.82%35.10%37.48%28.67%25.34%
Operating Margin
-20.54%-20.54%15.28%15.90%5.29%2.47%
Pretax Margin
-23.32%-23.32%14.22%17.56%6.14%1.22%
Profit Margin
-17.76%-17.76%10.60%10.38%4.38%0.48%
FCF Margin
-27.99%-27.99%-18.30%-15.88%-3.94%-2.76%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
--6.27---
PS Ratio
1.261.090.67---